Skip to main content
FTRE
NASDAQ Industrial Applications And Services

Court Order Sidelines Fortrea's New CFO; Board Director Steps In as Interim While Guidance Is Lifted

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$20.66
Mkt Cap
$1.958B
52W Low
$5.265
52W High
$21.12
52W Position info
292% above low
Off High info
2.2% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $5.265 on elevated volume (2.2× avg).

Summary

A court order has sidelined Fortrea's newly appointed CFO Jason Knoblauch, prompting the board to name director David Smith as interim CFO. Concurrently, the company posted Q2 results and raised its full-year guidance.


Key Events · Executive and Board Changes · FTRE

  • CFO Knoblauch Placed on Leave

    A Delaware court has granted a temporary restraining order that blocks newly appointed CFO Jason Knoblauch from working for Fortrea, after his prior employer sued over alleged restrictive covenant violations. He has been placed on paid leave.

  • Interim CFO Appointed

    Board director David Smith, who previously served as CFO of Charles River Laboratories (S&P 500), has been appointed interim CFO. His compensation includes $60,000 per month and RSUs valued at up to $900,000.

  • Q2 Results and Raised Guidance

    Fortrea reported Q2 revenue of $678.2 million and adjusted EBITDA of $58.7 million. Full-year 2026 guidance was raised to revenue of $2,620–$2,690 million and adjusted EBITDA of $205–$220 million.

  • Leadership Turmoil Risk

    The CFO disruption comes on the heels of the CAO's recent departure and the original CFO transition, injecting uncertainty into the finance function at a pivotal stage of the turnaround.


Analysis · FTRE · Industrial Applications And Services

Weeks after naming Jason Knoblauch CFO, Fortrea has placed him on paid leave following a Delaware court's temporary restraining order, sought by his former employer over alleged restrictive covenant breaches. Stepping into the breach is board director David Smith, a former S&P 500 CFO, who will receive $60K per month and up to $900K in RSUs. The abrupt disruption at the top of finance arrives alongside the company's Q2 report and a raised full-year outlook — a juxtaposition that demands careful scrutiny from investors.

At the time of this filing, FTRE was trading at $20.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $5.27 to $21.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Jul 29, 2026, 6:38 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $20.66
Real-time Price: $20.66 info
Change: $0 (0%) info
Market Cap: $1.958B info
FTRE
Jul 14, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.03
Real-time Price: $20.66 info
Change: +$2.63 (+15%) info
Market Cap: $1.958B info
FTRE
Jun 26, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.65
Real-time Price: $20.66 info
Change: +$3.01 (+17%) info
Market Cap: $1.958B info
FTRE
Jun 26, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $17.35
Real-time Price: $20.66 info
Change: +$3.31 (+19%) info
Market Cap: $1.958B info
FTRE
May 05, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.08
Real-time Price: $20.66 info
Change: +$6.58 (+47%) info
Market Cap: $1.958B info